ヒトの臓がん細胞系における光力学療法と併用した抗癌効果
Yazan S Khaled1, Kathleen Wright1, Alan Melcher2
1Section of Translational Anaesthesia and Surgery, St James's University Hospital, Leeds, UK.
Lancet (London, England)
|August 28, 2015
まとめ
この研究では,レオウイルス腫瘍解毒ウイルス療法と,プロトポルフィリンIX (PpIX) 媒介の光学療法を組み合わせることで,臓がんのモデルにおいて,癌細胞の死亡が著しく増加することが示されました. この新しい組み合わせの治療法は 臓がんの治療法として有望です
科学分野:
- 腫瘍学
- ウイルス学
- 生物化学
背景:
- 臓がんは,特に進行した,または手術不能な段階では,治療上の大きな課題を提示します.
- 腫瘍解毒ウイルス療法と光ダイナミック療法 (PDT) は,臓がんの治療の可能性のある新興の治療方法である.
研究 の 目的:
- レオウイルス解毒性ウイルス治療とプロトポルフィリンIX (PpIX) 媒介の光学療法 (PDT) の併用抗癌効果を調査する.
- ヒトの臓がん細胞系におけるこの併用アプローチの有効性を in vitro で評価する.
主な方法:
- 人間の臓がん細胞系 (PsPC - 1, BXPC - 3) と対照細胞系 (HEK293) は,細胞ごとに様々なプラーク形成ユニット (PFU) でレオウイルス血清型3株デアリング (T3D) で治療された.
- 細胞はPpIXを誘発するために5 - アミノレヴリン酸 (5- ALA) で化され,その後に光照射が行われました.
- 細胞活性は,メチルチアゾルテトラゾリウム (MTT) とトリパンブルーアッセイを使用して評価され,細胞毒性効果が決定されました.
主要な成果:
- レオウイルス単独治療は,臓がん系において有意な細胞死を引き起こした (最大57%).
- PpIXを介したPDT単独治療では,用量依存の細胞死が示されました.
- リオウイルスとPpIX媒介のPDTの組み合わせは,特定の濃度で100%の細胞死亡を達成し,細胞毒性の有意な増加をもたらしました (p=0. 042).
結論:
- この研究は,レオウイルス解毒ウイルス療法と,臓がんに対するPpIX介在PDTを組み合わせた最初のin vitro試験である.
- この組み合わせが新しい治療戦略であることを支持する,重要な添加細胞毒性効果を示しています.
- この併用治療の臨床的可能性を探るため,さらなる研究が必要である.
さらに関連する動画
関連する概念動画
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Tumor Immunotherapy
2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K


